ODDB.org: Open Drug Database

Home - 00662 - 01 - 011

HBVAXPRO 5, Injektionssuspension - Ampulle(n)

Swissmedic Key	00662011	Registration Holder	Sanofi Pasteur MSD AG
Name	HBVAXPRO 5, Injektionssuspension	Date of registration	20.08.2002
		Introduction of Sequence	20.08.2002
ATC-Classification	Hepatitis B, Purified Antigen (J07BC01)	Revision date
WHO	WHO-DDD	Valid until	13.08.2017
Index Therapeuticus (BSV)	08.08.	Show package size	Ampulle(n)
Index Therapeuticus (Swissmedic)	08.08.	Description
Swissmedic categorie.	B
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	22.42
Deductible	k.A.	Consumer price	42.10
Feedback	FB
GTIN	7680006620117	Medication Code	Impfstoffe
Pharmacode		Disponibility

Composition

hepatitidis B virus antigenum ADNr 5 µg, aluminium ut aluminii hydroxyphosphas sulphas amorphus, natrii boras, natrii chloridum, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml.

Packungsbestandteile

Galenic Form

Injection suspension

Excipiens

Active Agent	Dose
Hepatitidis b Virus Antigenum Adnr	5 µg

Inactive agents
Alumine
Natrii Boras
Sodium Chloride

Source

Data was imported : 04.12.2014 Swissmedic Registration : 00662 Sequence : 01 Product name : HBVAXPRO 5, Injektionssuspension Registration owner: : Sanofi Pasteur MSD AG Product group : Index Therapeuticus (BSV) : 08.08. Medication Code : Impfstoffe Date of registration : 20.08.2002 Valid until : 13.08.2017 Package number : 011 Show package size : 1 Commercial Form/Unit : Ampulle(n) Swissmedic categorie. : B Active Agents : hepatitidis B virus antigenum ADNr Composition : hepatitidis B virus antigenum ADNr 5 µg, aluminium ut aluminii hydroxyphosphas sulphas amorphus, natrii boras, natrii chloridum, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml.

2025	©ywesee GmbH